BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 17426631)

  • 1. Molecular Mechanisms in the Vascular and Nervous Systems following Traumatic Spinal Cord Injury.
    Li S; Dinh HTP; Matsuyama Y; Sato K; Yamagishi S
    Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36675958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targets and nanomaterial-based therapies for mitigation of secondary injury after spinal cord injury.
    Gao J; Khang M; Liao Z; Detloff M; Lee JS
    Nanomedicine (Lond); 2021 Sep; 16(22):2013-2028. PubMed ID: 34402308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Effect of BDNF-Overexpressing Human Neural Stem Cells (F3.BDNF) in a Contusion Model of Spinal Cord Injury in Rats.
    Chang DJ; Cho HY; Hwang S; Lee N; Choi C; Lee H; Hong KS; Oh SH; Kim HS; Shin DA; Yoon YW; Song J
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of inflammatory cytokines for spinal cord injury recovery.
    Lin S; Xu C; Lin J; Hu H; Zhang C; Mei X
    Histol Histopathol; 2021 Feb; 36(2):137-142. PubMed ID: 33001420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-β Plays a Detrimental Role in Experimental Traumatic Brain Injury by Enhancing Neuroinflammation That Drives Chronic Neurodegeneration.
    Barrett JP; Henry RJ; Shirey KA; Doran SJ; Makarevich OD; Ritzel RM; Meadows VA; Vogel SN; Faden AI; Stoica BA; Loane DJ
    J Neurosci; 2020 Mar; 40(11):2357-2370. PubMed ID: 32029532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Inflammatory Cytokines for Spinal Cord Injury Repair Through Local Delivery of Therapeutic Agents.
    Ren H; Chen X; Tian M; Zhou J; Ouyang H; Zhang Z
    Adv Sci (Weinh); 2018 Nov; 5(11):1800529. PubMed ID: 30479916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application.
    Roselli F; Chandrasekar A; Morganti-Kossmann MC
    Front Neurol; 2018; 9():458. PubMed ID: 29971040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement components of nerve regeneration conditioned fluid influence the microenvironment of nerve regeneration.
    Li GS; Li QF; Dong MM; Zan T; Ding S; Liu LB
    Neural Regen Res; 2016 Apr; 11(4):682-6. PubMed ID: 27212935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis.
    Croze E; Yamaguchi KD; Knappertz V; Reder AT; Salamon H
    Pharmacogenomics J; 2013 Oct; 13(5):443-51. PubMed ID: 22711062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated interferon-beta modulates the acute inflammatory response and recovery when combined with forced exercise following cervical spinal contusion injury.
    Sandrow-Feinberg HR; Zhukareva V; Santi L; Miller K; Shumsky JS; Baker DP; Houle JD
    Exp Neurol; 2010 Jun; 223(2):439-51. PubMed ID: 20109445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.
    Sättler MB; Williams SK; Neusch C; Otto M; Pehlke JR; Bähr M; Diem R
    Am J Pathol; 2008 Nov; 173(5):1496-507. PubMed ID: 18832577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.
    Donnelly DJ; Popovich PG
    Exp Neurol; 2008 Feb; 209(2):378-88. PubMed ID: 17662717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation of acute experimental spinal cord injury with human immunoglobulin G.
    Gok B; Sciubba DM; Okutan O; Beskonakli E; Palaoglu S; Erdamar H; Sargon MF
    J Clin Neurosci; 2009 Apr; 16(4):549-53. PubMed ID: 19200733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-level relationship for nitric oxide and the protective effects of aminoguanidine in experimental spinal cord injury.
    Soy O; Aslan O; Uzun H; Barut S; Iğdem AA; Belce A; Colak A
    Acta Neurochir (Wien); 2004 Dec; 146(12):1329-35; discussion 1335-6. PubMed ID: 15309585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats.
    Beril Gok H; Solaroglu I; Okutan O; Cimen B; Kaptanoglu E; Palaoglu S
    J Clin Neurosci; 2007 Feb; 14(2):138-42. PubMed ID: 17161287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acids and neurological injury.
    Michael-Titus AT
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):295-300. PubMed ID: 18036801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic strategies in the treatment of experimental spinal cord injury.
    Nockels R; Young W
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S211-7. PubMed ID: 1588610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of immunomodulation with human interferon-beta on early functional recovery from experimental spinal cord injury.
    Gok B; Okutan O; Beskonakli E; Palaoglu S; Erdamar H; Sargon MF
    Spine (Phila Pa 1976); 2007 Apr; 32(8):873-80. PubMed ID: 17426631
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.